EG ·
co approval 300 mg tab
co approval 300 mg tab
Composition
IRBESARTAN
· AMOUNT_PER_UNIT
HYDROCHLOROTHIAAZIDE
· AMOUNT_PER_UNIT
Registration
Packages and prices
85.00 EGP
Explainable alternatives
Candidates are informational and are not automatic authorization for substitution or dispensing.
| Product | Match | Differences | Price |
|---|---|---|---|
| kansartan 75MG 10/TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, route | 11 EGP |
| VEZIDANE 150/12.5 7 TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, route | 11 EGP |
| IRBESARTAN 300MG 7TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form | 12 EGP |
| IRBEDRIN - DIU 150 12.5 MG 10 TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis | 13.2 EGP |
| IRBETAN 150MG 10TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form | 14.4 EGP |
| kansartan 150 MG tab 10 | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, route | 14.4 EGP |
| IRBEDRIN 150 MG 10 TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, route | 14.4 EGP |
| IRBEDRIN 75MG 14TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form | 15 EGP |
| IRBESARTAN 75MG 14TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form | 15 EGP |
| Irbezide 10tab | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form | 15.6 EGP |
| XTENSION 150 MG 14 TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis | 17 EGP |
| IRBEVASC PLUS 300\12.5 MG 7 TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, route | 17.5 EGP |